Human Microbiome Drug TargetsGenevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, Maria Catherine B OteroHäftad, 20242 929 kr
Valeur diagnostique et pronostique de la procalcitonine chez les patients atteints de tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025909 kr
Valore diagnostico e prognostico della procalcitonina nei pazienti affetti da tubercolosiRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Wartośc diagnostyczna i prognostyczna prokalcytoniny u pacjentów z gruźlicąRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valor diagnóstico e prognóstico da procalcitonina em pacientes com tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valor diagnóstico e prognóstico da procalcitonina em pacientes com tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valeur diagnostique et pronostique de la procalcitonine chez les patients atteints de tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025909 kr
Wartośc diagnostyczna i prognostyczna prokalcytoniny u pacjentów z gruźlicąRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valore diagnostico e prognostico della procalcitonina nei pazienti affetti da tubercolosiRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Human Microbiome Drug TargetsGenevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, Maria Catherine B OteroHäftad, 20242 929 kr